Brief: Kiora Pharmaceuticals Inc - Effective As Of June 16, 2022, Drexler Resigned As Interim Chief Financial Officer Of Company
21/06/2022 23:25
June 21 (Reuters) - Kiora Pharmaceuticals Inc KPRX.O :
* KIORA PHARMACEUTICALS INC - EFFECTIVE AS OF JUNE 16, 2022,
DREXLER RESIGNED AS INTERIM CHIEF FINANCIAL OFFICER OF COMPANY
Source text: [ID: https://bit.ly/3tR1NMq]
Further company coverage: KPRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiora Pharmaceuticals
See all newsKiora Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kiora Pharmaceuticals, Inc. expected to post a loss of 62 cents a share - Earnings Preview
Brief: Kiora Pharmaceuticals Inc - Enters Securities Purchase Agreement On April 3, 2026 - SEC Filing
Kiora Pharmaceuticals posts 2025 net loss as expenses rise
Brief: Kiora Pharmaceuticals Files For Mixed Shelf Offering Of Up To $100 Million- SEC Filing